Tagaya H

No ORCID on file · 5 papers in corpus
article 2026
Gut Microbiota Changes After Hormonal or Surgical Treatment for Endometriosis
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70211

PURPOSE: Although studies have suggested a link between gut microbiota and endometriosis pathophysiology, the effects of treatment for endometriosis remain unclear. METHODS: In this prospective observational study, 27 patients with stage I…

2026
Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist.
Frontiers in medicine ·doi:10.3389/fmed.2026.1704529

BackgroundRelugolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, represents a potentially effective and less invasive therapeutic approach for retained products of conception (RPOC). However, its impact on subsequent pregnancy…

other 2025
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion
Scientific reports ·doi:10.1038/s41598-025-13855-x

The fibrosis mechanism in endometriosis is not elucidated. We investigated the role of eosinophil in fibrosis of endometriosis. The endometriotic stromal cells (ESCs) and endometrial epithelial cells (EECs) were subjected to in vitro experi…

article 2023
Effectiveness of Laparoscopic Adenomyomectomy on Perinatal Outcomes
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_45_22

OBJECTIVES: The objective of this study was to observe the influence of laparoscopic adenomyomectomy on perinatal outcomes. MATERIALS AND METHODS: The retrospective cohort study included 43 pregnant cases with adenomyosis who did not under…

2022
Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy.
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_9_22

For preparing the optimal condition in transcervical resection (TCR) surgery, gonadotropin-releasing hormone (GnRH) agonist has been utilized. Recently, an oral GnRH antagonist (relugolix) is available and acts directly on GnRH receptor, av…